Reliq Health Technologies Inc V.RHT.H

5 NEW CONTRACTS/2500 PATIENTS TO BEGIN BOARDING IN APRIL2022

[Humanist]

Reliq Health Technologies, Inc. Announces 5 New Contracts in Nevada, California and Texas
 by @nasdaq on 3 Mar 2022, 03:01
   
HAMILTON, Ontario, March 03, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed 5 new contracts with physician practices in Nevada, California and Texas.

“We are very excited to be expanding into Nevada with three new physician practices,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Over 1 million residents of Nevada have chronic conditions like hypertension, arthritis, diabetes and kidney disease.

Nevada is ranked 47^th out of 50 US States in terms of the ratio of physicians to residents, making access to care a significant challenge for patients across the State. Using Reliq’s iUGO Care platform, clinicians in Nevada can provide high quality, proactive, preventative care to more patients, improving access to care and health outcomes for at-risk patients.
We are also pleased to add two new primary practices in California and Texas.

Together these five clients are expected to add over 2,500 new patients to Reliq’s platform. We expect to begin onboarding patients from these practices in April, 2022 and to generate revenue of $50 per patient per month.”

Reliq Health
Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company Contact
Investor Relations at [e-mail]
US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
[e-mail]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Reliq Health Technologies Inc.

[lscfa]

New contracts already included in guidance so stock should not move..... When we talk about guidance, the difference between guidance, which is also obviously forward-looking and a forecast, is that the difference between that and revenue run rate is that guidance includes some of the expected growth over the year. So revenue run rate is really just clients that we've signed contracts with

[Heyduu]

Hello, what do you think ist a fair price for the stock? I am interresting!!

[vitalina2233]

1 grand

[lscfa]

    $mil cdn. 2022 est. 2023 est. 2024 est. Revenue 40.0 65.0 120.0 45% ebitda 18.0 29.3 54.0 Diluted shs  205

[ssdasmm]

So in that case, if they already new this contract was in the pipline, then they know other contracts are in the pipeline and will be signed, hence the guidance of 40 million this year should be achieved.

[lscfa]

If the $40 million revenue guidance is achieved for C2022 it will be mostly in Q3 and Q4. I expect  Jan/Feb/mar qtr to disappoint because co. keeps repeating that it's run rate at Dec 31/21 was $2 million/month but that is a bogus no. because revenue generation starts 2 to 3 months later. When we talk about revenue recognition when we report revenue in the financials, so sales, this is

[lscfa]

an alternative scenario is cyq1 has a large revenue bump due to a one-time hardware sale and then cyq2 revenues actually are lower than cyq1.      

[AdeptMind]

That is an interesting theory.  I was also thinking that large hardware purchase should be forthcoming in the Q, whether that would make the Q even larger than the one proceeding it is up to how effective the company is at their predictions of rate of onboards.

[Nicksonsnowboar]

I like this company but it has broken all resistance points to the downside in relatively short order Be interesting to see how far she falls . Next stop is .85 . If getting on naz is still on the table they need to break this extended 40%+ drop. 

[vitalina2233]

Where do we get these clowns,what a stupid thing to say We got  DANCER AND DASHER,COMET AND BASHER WE GOT VIXEN,CUPID DONNER AND STUPID  GEESH   PAPI

[Coppergirl]

Hi Papi i don't get the price action here  we're in the best position we have ever been in and huge growth on the table  Any thoughts ?

[vitalina2233]

I have no idea,just rookies and weak hands. There's no reasoning in my mind.. The bashers are winning.  I aint going no where. Perhaps i'll buy more. Sorry  Papi

[Coppergirl]

Thx  My thoughts exactly 

[vitalina2233]

yw  im baffled,this should be green  volumes back up the last few days,i always say one think  For every seller there's a buyer Papi

[SupremeNed]

interest rates going up in Canada. Usually interest rate hikes are tough on the stockmarket. my opinion

[Jamesedgar1]

Interesting take on Healthcare stocks. GLTA https://www.wealthprofessional.ca/news/industry-news/what-do-rate-hikes-and-inflation-mean-for-healthcare-stocks/363380

[aaaaaargh]

Buy financials!

[EdinColorado]

The safest place to be is in commodities during this scary time.  I am guessing that those who would normally buy into speculative stocks like RHT are moving money to commodities, which also have high rewards possibilities now too. I was already heavily in commodities, so I didn't need to liquidate anything to buy them. RHT is immensely oversold and its descent isn't sustainable. If

[EdinColorado]

I tend to place Putin Puppets that blame Biden for a falling stock market and the price of gas on ignore. The alternative to sanctions was a direct military conflagration between two nuclear superpowers, something our U.S. mainstream media try to push every chance they get. They want Trump and their ratings boosted by outrage back, and so do the crazies trolling all kinds of social media sites

[Nicksonsnowboar]

Early yet but .85 has been broken and the ask outweigh the bids b a 3:1 margin . Not a good sign . Next stop .82

[teeswater]

yes,  unfortunately, will be heading into 70's early next week I think this will continue to drop daily until substantial news release

[SupremeNed]

81 cents bottom in my opinion. 

[ssdasmm]

Could be but looking forward to Q3, Q4 and beyond. The Data Soft Logic partnership will be live with clients as of April 2022, with uncertain revenues in calendar year 2022, but expected new revenues of $36 million each year starting in 2023 (i.e. $72 million expected in 2024, and so on);